Global Fluoxetine Market Size, Share and Trends Analysis Report, By Type (10mg and 20mg), By Application (Depression, Obsessive Compulsive Disorder, Panic Disorder, Bulimia Nervosa, and Others), Forecast (2022-2028)

The global fluoxetine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Fluoxetine is used to treat patients with depression, panic attacks, obsessive-compulsive disorder, bulimia disorder, and some form of premenstrual syndrome. This drug improves mood, sleep, appetite, and energy level and restores interest in daily living. The global fluoxetine market is growing due to the increasing prevalence of depression and bipolar disorder patients globally. According to FDA, depression is considered a disabling illness that is expected to lead to suicidal thoughts among people. The off-label recommendation and prescription of anti-depressant and anti-anxiety drugs are driving the growth of the market. The market is also increasing due to the changing lifestyle and increasing societal pressures aid in the high suicidal tendencies, primarily among young adults that leads to depression. According to the World Health Organization 2021, it is estimated that 5% of the world’s adult population suffers from depression. According to World Health Organization 2020, an estimation of 1 million suicides cases was registered due to depression every year. China alone approximately registered 90 million depression patients. Additionally, the research and development of major market players for the manufacturing of generic drugs as a substitute for the branded drug which will be cheaper but equally effective are boosting the growth of the global mirtazapine drug market in the forecast period.

For instance, in August 2019, Lupin Ltd. announced their launch of fluoxetine tablets in 10mg and 20 mg form after getting approval from US Food and Drug Administration. This drug is the generic version of Eli Lilly and Co. drug Prozac Tablets. In March 2019, Upsher-Smith Laboratories, LLC announced their launch of a generic version of fluoxetine tablets in 10 mg and 20 mg variants in the US market. In April 2020, Aurobindo Pharma received the USFDA approval to manufacture and market the generic version of fluoxetine tablet in 10 mg and 20 mg variants.

Some major players in the market include Alvogen, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Zydus Group, and Sun Pharmaceutical Industries Ltd. among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new drug launches, to stay competitive in the market. For instance, according to Drug for Neglected Diseases 2022, a clinical trial for COVID-19 in low-resource settings is under process to test a new combination treatment known as ANTICOV. This ANTICOV drug combination includes fluoxetine and is added based on some different mechanism other than anti-depressant properties. This fluoxetine prevents the ability of the virus to replicate by preventing viral entry into cells and could also carry immunosuppressive activity it is expected to reduce deaths and hospitalization by 30%.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Zydus Group, and Sun Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Fluoxetine Market Report by Segment

By Type

• 10 mg
• 20 mg

By Application

• Depression
• Obsessive compulsive disorder
• Panic disorder
• Bulima Nervosa
• Others

Global Fluoxetine Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa